Evolus (EOLS) Asset Writedowns and Impairment (2019 - 2025)
Evolus (EOLS) reported Asset Writedowns and Impairment of $2.2 million for Q3 2025, up 148.59% on a YoY basis from $889000.0 in Q3 2024, and up 214.37% quarter-over-quarter from $703000.0 in Q2 2025.
Evolus (EOLS) Asset Writedowns and Impairment (2019 - 2025) Analysis & Trends
Evolus has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $2.2 million in Q3 2025.
- For the quarter ending Q3 2025, Asset Writedowns and Impairment rose 148.59% year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2025 stood at $4.8 million (up 172.44% YoY), and the FY2024 full-year result was $2.4 million, up 70.07% from the prior year.
- Asset Writedowns and Impairment for Q3 2025 stood at $2.2 million, up from $703000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $2.2 million in Q3 2025, with the low at -$297000.0 in Q2 2021.
- Historically, Asset Writedowns and Impairment has averaged $528421.1 across 5 years, with a median of $465000.0 in 2022.
- Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment slumped 76.6% — and 2024, when it soared 818.6%.
- Evolus' Asset Writedowns and Impairment stood at $88000.0 in 2021, then jumped by 167.05% to $235000.0 in 2022, then tumbled by 63.4% to $86000.0 in 2023, then soared by 818.6% to $790000.0 in 2024, then surged by 179.75% to $2.2 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $2.2 million (Q3 2025), $703000.0 (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 703,000.00 |
| Jun 30, 2025 | 703,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 790,000.00 |
| Dec 31, 2024 | 790,000.00 |
| Sep 30, 2024 | 889,000.00 |
| Sep 30, 2024 | 889,000.00 |
| Jun 30, 2024 | 582,000.00 |
| Jun 30, 2024 | 582,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Sep 30, 2023 | 1.01 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 69,000.00 |